Expression and characterization of recombinant l-asparaginase from Pseudomonas fluorescens - PubMed

Expression and characterization of recombinant l-asparaginase from Pseudomonas fluorescens

R Sindhu et al. Protein Expr Purif. 2018 Mar.

Abstract

l-asparaginase (E.C. 3.5.1.1), an anti-cancer drug has been used in the treatment of acute lymphoblastic leukemia. A novel source of l-asparaginase from Pseudomonas fluorescens was addressed in the present studies. The ANS gene in Pseudomonas fluorescens MTCC 8127 which produces l-asparaginase was cloned and expressed in E. coli BL21 (DE3). The expressed recombinant protein (PfAns) which was purified, showed l-asparaginase activity. The enzyme was further characterized. The pH and temperature optima were found to be 7.5 and 37 °C. The recombinant enzyme was stable to temperature and pH. The enzyme was homotetramer with the molecular weight of the monomer being 35 kDa and a whole protein molecular weight of 140 kDa. The purified l-asparaginase had a specific activity of 26 U/mg with a K_m and V_max of 0.050 M and 4.032 mol^-1min. The enzyme exhibited a high affinity towards l-asparagine and showed a very minimal activity with glutamine as a substrate. The enzyme activity was inhibited by PMSF, suggesting the presence of serine at the active site. The presence of Mg²⁺ enhanced PfAns activity by 49%, and SDS strongly inhibited the enzyme activity. The in vitro half-life of the recombinant enzyme was ∼40 h. The enzyme demonstrated deglycosylation activity which could exhibit an additional barrier for proliferating cancer cells.

Keywords: Characterization; EcoAns; L-asparaginase; PfAns; Pseudomonas fluorescens; Recombinant enzyme.

Similar articles

• What makes a good new therapeutic L-asparaginase?

  Beckett A, Gervais D. Beckett A, et al. World J Microbiol Biotechnol. 2019 Sep 24;35(10):152. doi: 10.1007/s11274-019-2731-9. World J Microbiol Biotechnol. 2019. PMID: 31552479 Review.

• Production of a Novel Marine Pseudomonas aeruginosa Recombinant L-Asparaginase: Insight on the Structure and Biochemical Characterization.

  Izadpanah Qeshmi F, Homaei A, Khajeh K, Kamrani E, Fernandes P. Izadpanah Qeshmi F, et al. Mar Biotechnol (NY). 2022 Jun;24(3):599-613. doi: 10.1007/s10126-022-10129-9. Epub 2022 May 4. Mar Biotechnol (NY). 2022. PMID: 35507234

• Expression, purification, and characterization of asparaginase II from Saccharomyces cerevisiae in Escherichia coli.

  Lopes W, Santos BAFD, Sampaio ALF, Gregório Alves Fontão AP, Nascimento HJ, Jurgilas PB, Torres FAG, Bon EPDS, Almeida RV, Ferrara MA. Lopes W, et al. Protein Expr Purif. 2019 Jul;159:21-26. doi: 10.1016/j.pep.2019.02.012. Epub 2019 Mar 2. Protein Expr Purif. 2019. PMID: 30836141

• Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant L.Asparaginase.

  Saeed H, Soudan H, El-Sharkawy A, Farag A, Embaby A, Ataya F. Saeed H, et al. Protein J. 2018 Oct;37(5):461-471. doi: 10.1007/s10930-018-9789-3. Protein J. 2018. PMID: 30097831

• [Bacterial recombinant L-asparaginases: properties, structure and anti-proliferative activity].

  Sokolov NN, Eldarov MA, Pokrovskaya MV, Aleksandrova SS, Abakumova OY, Podobed OV, Melik-Nubarov NS, Kudryashova EV, Grishin DV, Archakov AI. Sokolov NN, et al. Biomed Khim. 2015 May-Jun;61(3):312-24. doi: 10.18097/PBMC20156103312. Biomed Khim. 2015. PMID: 26215408 Review. Russian.

Cited by

• Microbial L-asparaginase for Application in Acrylamide Mitigation from Food: Current Research Status and Future Perspectives.

  Jia R, Wan X, Geng X, Xue D, Xie Z, Chen C. Jia R, et al. Microorganisms. 2021 Aug 3;9(8):1659. doi: 10.3390/microorganisms9081659. Microorganisms. 2021. PMID: 34442737 Free PMC article. Review.

• Thermostable bacterial L-asparaginase for polyacrylamide inhibition and in silico mutational analysis.

  Sundaram SS, Kannan A, Chintaluri PG, Sreekala AGV, Nathan VK. Sundaram SS, et al. Int Microbiol. 2024 Dec;27(6):1765-1779. doi: 10.1007/s10123-024-00493-y. Epub 2024 Mar 23. Int Microbiol. 2024. PMID: 38519776

• What makes a good new therapeutic L-asparaginase?

  Beckett A, Gervais D. Beckett A, et al. World J Microbiol Biotechnol. 2019 Sep 24;35(10):152. doi: 10.1007/s11274-019-2731-9. World J Microbiol Biotechnol. 2019. PMID: 31552479 Review.

• Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.

  Shishparenok AN, Gladilina YA, Zhdanov DD. Shishparenok AN, et al. Int J Mol Sci. 2023 Oct 16;24(20):15220. doi: 10.3390/ijms242015220. Int J Mol Sci. 2023. PMID: 37894901 Free PMC article. Review.

• Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems.

  Lefin N, Miranda J, Beltrán JF, Belén LH, Effer B, Pessoa A Jr, Farias JG, Zamorano M. Lefin N, et al. Front Pharmacol. 2023 Jun 22;14:1208277. doi: 10.3389/fphar.2023.1208277. eCollection 2023. Front Pharmacol. 2023. PMID: 37426818 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations